Jess Thomas

verano Brands

Verano to Release U.S. GAAP Fourth Quarter and Full Year 2021 Financial Results on April 27th and First Quarter 2022 Results on May 25th

Company Also Announces Submission of MCTO Application. Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) ("Verano" or the "Company"), a leading multi-state cannabis company, today announced it will release U.S. GAAP financial results for the fourth quarter and full year ended December 31, 2021, before the market opens on Wednesday, April 27, 2022, and also announced it will release first quarter results for the quarter ended on March 31, 2022, before the market opens on May 25, 2022.
Vitafoods-2021

Event Preview: Vitafoods Europe Returns in May 2022

Vitafoods Europe is back once again — at its usual May timeslot — combining an online platform and the in-person event in Geneva to reconnect and inspire the nutraceutical community in an ever-changing and increasingly health-conscious, post-COVID world.
A picture of a human brain

HMNC Brain Health and Develco Pharma Announce Promising Preliminary Results in Treatment-Resistant Depression (TRD)

HMNC Brain Health ("HMNC'' or the "Company"), a global clinical stage biopharmaceutical company pioneering the development of personalized therapies in psychiatry, together with Develco Pharma, a company specializing in the development and manufacture of orally administered modified, prolonged & chrono release drugs today announced promising top-line results from the Phase 2 Proof-of-Concept investigator-initiated trial of its oral prolonged-release formulation of ketamine (KET01) in Treatment-Resistant Depression (TRD).
1 2 3 4 5 6 7 8

Recommended Stories

Real Time Analytics